Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Alliance Healthcare team raises thousands with charity bike ride to Paris

Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.


Matt Addison, VP Operations, Alliance Healthcare, who created the Tour D’Alliance series back in 2019 said: “This year we took the challenge international, and the sponsorship and support has been incredible.

“We were determined to raise as much as possible to help young children and their families during the most difficult times. Over £55,000 raised for Theodora Children’s Charity is an amazing amount and I am proud of the team who knew that with every painful pedal, we were doing our bit to help a very worthy cause.”

Ellen Blessington, Senior Community and Communications Fundraiser said: “We are incredibly grateful to have been supported in this year’s Tour D’Alliance. Being ill and needing medical treatment is difficult at any point in life, but when you are a child, it can be particularly confusing and frightening.

"Thanks to the cyclists taking on the challenge of 300 miles, over 2,400 children will receive a magical Giggle Doctor visit, helping reduce their stress and anxiety, create opportunities for play and transform their hospital experience.

"From all of us at Theodora Children’s Charity, including our Giggle Doctors, our heartfelt thanks go to the cyclists, drivers, sponsors and everyone who made this challenge."

More For You

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less